The Capitol LedgerEvery move in Congress, on the record
HomeBillsRecordsLedger AI

The Capitol Ledger

Built from the Congressional Record and Congress.gov. Every summary links to its source.

AboutFAQFeedbackTerms of ServicePrivacy Policy
Follow us onlineInstagram

Summaries are AI-generated from primary sources. Verify anything important against the original record.

The Capitol Ledger

Built from the Congressional Record and Congress.gov. Every summary links to its source.

The projectAboutFAQFeedback
LegalTerms of ServicePrivacy Policy
Follow us onlineInstagram

Summaries are AI-generated from primary sources. Verify anything important against the original record.

All bills
H.R. 3698·119th Congress·Introduced Jun 3, 2025

Living Organ Donor Tax Credit Act

IntroducedTaxationMajor
View bill text
Sponsor
Rep. Wilson, Joe [R-SC-2]
Committees
Energy and Commerce Committee (primary)
Last action
Jun 3, 2025

Bottom line

The bill seeks to increase living organ donation rates by alleviating the financial burden on donors through a federal tax credit, while explicitly maintaining the ethical framework of organ transplantation.

What it actually does

This bill establishes a new refundable federal income tax credit, up to $5,000, for individuals who donate a qualified life-saving organ. The credit covers various donation-related expenses, including medical costs, travel, lodging, legal fees, and lost wages. Crucially, it also amends existing federal law to clarify that this tax credit does not constitute unlawful compensation for organ donation.

Proponents argue

Proponents argue that this legislation is a vital step to address the critical shortage of organs for transplantation by removing significant financial barriers for altruistic living donors. They contend that covering expenses like lost wages and medical follow-up costs will encourage more individuals to donate, ultimately saving lives and improving patient outcomes.

Opponents contend

Opponents might raise concerns about the potential cost to federal revenue from a new refundable tax credit, especially without a specified offset. Some critics could also argue that, despite the bill's explicit legal clarification, any financial incentive, however indirect, could still raise ethical questions about the commodification of human organs or potentially pressure vulnerable individuals into donation.

The bill is exceptionally concise and clearly written, allowing an informed reader to understand its core provisions and implications within minutes.

Section 2(a), inserting new Section 36C into the Internal Revenue Code.

Establishment of the Living Organ Donor Tax Credit

prominently featuredstraightforward

This provision creates a new refundable tax credit for individuals who donate a qualified life-saving organ. The credit is designed to reimburse various costs associated with the donation, including medical expenses, travel, lodging, legal fees, and lost wages, up to a maximum of $5,000 per donor per taxable year. The refundable nature means individuals can receive the credit even if it exceeds their tax liability.

GroupImpactMechanismScale
GroupLiving organ donorsImpactFinancial benefit (reimbursement of costs, compensation for lost wages)MechanismDirect tax credit against federal income tax liability.ScaleUp to $5,000 per donation.
GroupOrgan transplant recipientsImpactIncreased availability of organsMechanismReduced financial barriers for potential donors.ScalePotentially significant, depending on donor response.

Supporters argue

Supporters argue this credit directly addresses the financial disincentives that prevent many individuals from becoming living organ donors, thereby increasing the pool of available organs and saving lives. It recognizes the altruistic act of donation by mitigating personal financial sacrifice.

Critics contend

Critics might argue that while well-intentioned, the $5,000 cap may not fully cover all expenses for some donors, especially those with significant lost wages or extensive travel, thus limiting its effectiveness. Concerns could also be raised about the overall cost to federal revenue without a clear offset.

Tradeoffs

The bill balances the desire to incentivize life-saving donations with the need to manage federal budget impacts and avoid creating a system that could be perceived as commodifying organs.

Section 2(a), new Section 36C(c) of the Internal Revenue Code.

Scope of Eligible Organs and Donor Conditions

prominently featuredstraightforward

This section defines 'qualified life-saving organ' to include kidneys, livers, lungs, pancreases, intestines, bone marrow, or parts thereof. It explicitly states that the credit is only for living donors (organ removed while donor is alive), requires the donation and transplantation to occur within the U.S. and in accordance with U.S. laws, and excludes any expenses already reimbursed by other parties to prevent double-dipping.

Section 2(b), amending the Public Health Service Act and the National Organ Transplant Act.

Legal Clarification for Tax Credit and Organ Compensation

prominently featuredmoderately complex

This provision amends the Public Health Service Act to ensure that receiving this tax credit does not disqualify an individual from federal living organ donation grants. Crucially, it also amends the National Organ Transplant Act (NOTA) to explicitly state that this tax credit is not considered unlawful compensation for organ donation, thereby removing a potential legal ambiguity and protecting donors and transplant professionals.

About this analysis. AI-Generated from the official bill text and available committee reports. Gaps in available data are noted explicitly. Verify important details with the official Congress.gov record.

On this page

  • Executive summary
  • Key provisions
  • Follow the money
  • Critical analysis
  • Questions to ask
  • Implementation
  • Political analysis
Ask Ledger AI about this